SEC 13F Intelligence

Global Alpha Capital Management Ltd. / EBS

Global Alpha Capital Management Ltd.’s Emergent Biosolutions Inc Position

Does Global Alpha Capital Management Ltd. own Emergent Biosolutions Inc (EBS)? Not currently — the last reported position was 606.5K shares worth $13M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q3 2022
Shares
606.5K
% of Portfolio
+1.27%
Quarters Held
5
position exited

Position History EBS

Reported value by quarter
Q3 ’21: $17MQ3 ’21Q4 ’21: $14MQ4 ’21Q1 ’22: $19MQ1 ’22Q2 ’22: $13MQ2 ’22Q3 ’22: $13MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2022606.5K$13M+1.27%
Q2 2022418.0K$13M+1.40%
Q1 2022460.5K$19M+1.62%
Q4 2021330.3K$14M+1.39%
Q3 2021340.0K$17M+1.89%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Alpha Capital Management Ltd.’s full portfolio or all institutional holders of EBS.